The 2016 estimate of $818 billion for dementia related expenses is expected to surpass 1 tril lion dollars by the end of 2018.
Introduction Life expectancy has increased over the past 100 years. This has been attributed to ad vances in areas such as nutrition, education, san itation, and medicine. 1 Developments in medical science have been critically important to these ad vancements as the world has progressed through mortality milestones. Exactly 100 years ago, the globe was shaken by the 1918 influenza pan demic, illustrating the impact of infectious diseas es at the time. With the advent of antibiotics and vaccinations, the era of infectious diseases gave way to a time where mortality became dominat ed by heart diseases and cancer. Improved strate gies to manage cardiovascular risk factors, as well as treat cardiac disease and cancer, have lessened their grip upon the global society. From 2000 to 2014, the United States saw a decrease in the per centage of deaths due to heart disease (by 14%), stroke (by 21%), breast cancer ( by 1%), prostate cancer (by 9%), and HIV (by 54%).
2
Neurodegenerative diseases are age related, meaning that their prevalence increases as more persons live into the risk period. Many of these diseases result in dementia, of which Alzheim er disease (AD) is the most common, accounting for 60% to 80% of all cases of dementia.
3 From 2000 to 2014, the percentage of deaths attribut ed to AD increased by 89%. 2,4 Unfortunately, no treatment has been discovered to delay or pre vent the disease so there has been a substantial increase in AD prevalence. In 2016, the estimat ed number of 47 million individuals with demen tia worldwide was projected to triple by 2050.
hearing loss cohorts were associated with high er risk of dementia incidence. 30 A recent meta analysis demonstrated that cognitively normal individuals with hearing loss were at greater risk of developing dementia (relative risk [RR], 1.94; 95% CI, 1.38-2.73). 9 Visual impairment has also been implicated as a risk factor for cognitive dysfunction. Best corrected vision worse than 20/40 was associat ed with accelerated cognitive and functional de cline. 16, 17 However, a recent longitudinal study showed no association between the incidence of dementia and visual impairment defined as best corrected vision of worse than 6/12 in the more impaired eye. It is unclear if education beyond high school pro vides an additional protective effect. One theo ry to explain these findings is called cognitive re serve, which has received a substantial amount of attention within the scientific literature ever since the Katzman's observation that some patients with postmortem AD pathology were asymptom atic. 11 These patients were found to have an in creased number of large pyramidal neurons. It is currently unclear whether this resilience is the re sult of a more favorable brain parenchyma sub strate or more effective utilization of brain net works resulting in a higher symptomatic thresh old to cognition related pathology. 12 Another factor that is intertwined with edu cation is innate cognitive ability. For example, the Scottish Mental Survey of 1932 gathered IQ scores for all children born in 1921 and attending school in Scotland. 13 A subsequent study found that children who had higher IQs at the age of 11 years had less chance of developing dementia in their 70s. 14 Many hypotheses have been put forward on the basis of these data. For example, researchers investigated if intellectually gifted children go on to have more education and per form cognitively challenging jobs or if the factors that make children intellectually more talented also decrease the chance of dementia.
Sensory impairment Studies indicated, through retrospective analysis, that hearing loss is a risk factor for cognitive decline.
15 -20 There is now a substantial amount of supportive evidence from prospective studies. 21-24 Hearing loss is as sociated with an increased incidence of demen tia and also a faster rate of cognitive decline even when controlling for other potential confound ers such as age, APOEε4 allele status, and educa tion. 25 Cognitive decline appears greatest in indi viduals with severe hearing loss who do not use hearing aids.
26 Even self reported hearing impair ment has been associated with accelerated cog nitive decline that is attenuated with the use of hearing aids.
27 Some studies have failed to show an association between hearing loss and cogni tive decline.
28,29 A large retrospective longitu dinal study showed no association in unilateral hearing loss, while bilateral and side unspecified incident dementia. 53 Specifically, low social par ticipation (RR, 1.41; 95% CI, 1.13-1.75), less fre quent social contact (RR, 1.57; 95% CI, 1.32-1.85), and more loneliness (RR, 1.58; 95% CI, 1.19-2.09) were associated with incident dementia. These findings underscore the importance of social re lationships and a strong support network.
Alcohol use The complex effect of alcohol on neurological function has led some authors to suggest a U shaped relationship between alco hol consumption and negative brain outcomes. 54 Light to moderate drinking has been associat ed with a lower risk of dementia, 55,56 whereas chronic heavy alcohol use is associated with well established entities, such as Korsakoff syndrome. Moderate alcohol use has been less clearly de fined with regard to the risk of adverse cogni tive outcomes. A recent study in the United King dom demonstrated a dose dependent relation ship between alcohol consumption and hippo campal atrophy, with a faster decline in lexical fluency among those with higher alcohol use. 54 This study, consisting of 30 years of recurrent cognitive testing, failed to demonstrate a protec tive effect of light drinking, raising concerns re garding previous claims of a protective effect of light alcohol intake.
Diet There appears to be an association between dietary nutrients and cognitive performance.
57,58
Oxidative stress and vascular impairments are thought to contribute to cognitive decline. This has led many investigators to focus efforts on the role of antioxidants in disease prevention. The Mediter ranean diet contains many antioxidant rich foods, such as nuts, berries, and red wine. The Prevención con Dieta Mediterránea (PREDIMED) was a multi center trial of 7447 people with high cardiovascular risk that were randomized to a Mediterranean diet supplemented with extra virgin olive oil, a Medi terranean diet supplemented with mixed nuts, or a control diet (low fat). 59 Those in the treatment groups experienced a reduced incidence of ma jor cardiovascular events. Valls Pedret et al 60 fol lowed 447 cognitively healthy persons enrolled in PREDIMED. 60 They found that the Mediterra nean diet supplemented with olive oil or nuts is associated with improved cognitive function mea sured by changes in memory and frontal cognition scores. A separate study of 552 PREDIMED partic ipants showed cognitive improvements measured by the Mini Mental Status Examination and clock drawing test. 61 The Dietary Approaches to Stop Hypertension (DASH) diet is also associated with neurocognitive improvements in executive func tion, memory, and learning. 62 
Morris et al
63 proposed a hybrid of the Mediter ranean and DASH diets called the Mediterranean DASH Intervention for Neurodegenerative De lay (MIND), which emphasizes the components of each diet thought to provide neuroprotec tion. 63 They found that the MIND diet was as sociated with a slower rate of cognitive decline. meta analysis included 2 studies showing an in creased OR of developing all cause dementia among individuals with anxiety (OR, 2.05; 95% CI, 1.29-3.28).
Physical activity Physical activity helps reduce the risk of cerebrovascular diseases, diabetes, obesity, and hypertension. 39 This may explain, in part, the inverse relationship between physi cal activity and the risk of cognitive decline.
40,41
A previous meta analysis of 16 prospective stud ies found that higher levels of physical activity were associated with a lower risk of dementia (RR, 0.72; 95% CI, 0.60-0.86) and AD (RR, 0.55; 95% CI, 0.36-0.84). 42 However, this study exclud ed cases of dementia without a diagnosis of neu rodegenerative disease. Sofi et al 43 aimed to de termine the effect of physical activity on cogni tive decline among individuals without demen tia. Their meta analysis of 15 prospective stud ies demonstrated that subjects who performed a high level of physical activity were significantly protected against cognitive decline at follow up (HR, 0.621; 95% CI, 0.54-0.70). 43 In the Domi nantly Inherited Alzheimer Network study, 44 indi viduals carrying an autosomal dominant AD gene mutation who did more aerobic exercise accumu lated less amyloid in the brain measured on pos itron emission tomography scan. A recent study of Swedish women found that high cardiovascu lar fitness in midlife, as measured by maximal er gometer cycling testing, was associated with a de creased risk of incident dementia over a 44 year follow up (HR, 0.12; 95% CI, 0.03-0.54).
45
One of the most compelling studies is a ran domized single blind prospective trial on 120 cog nitively normal individuals who were random ized to either toning, stretching, and balancing or aerobics.
46 After 1 year, those in the aerobics group showed an increase in anterior hippocam pal volume and improvements in spatial memo ry. Hippocampal volume correlated with fitness and greater serum levels of brain derived neuro trophic factor. A recent literature review looked at the evidence supporting several forms of physi cal activity as a preventative measure against cog nitive decline and Alzheimer type dementia but was not conclusive.
47
Social isolation There is a growing body of ev idence suggesting that social isolation is a risk factor for hypertension, 48 coronary heart dis ease, 49 and depression, 50 all of which have been established as risk factors for cognitive decline.
32
A European study found that both men and wom en from Finland and Denmark with less social contact had greater functional decline at 5 year follow up.
51 A large meta analysis including 308 849 individuals found an association between survival and complex measures of social integra tion (OR, 1.91; 95% CI, 1.63-2.23). 52 A recent meta analysis by Kuiper et al 53 assessed 19 pro spective studies to find a relationship between several social relationship factors and the risk of require a prescription, many others are available as over the counter purchases. It has been well demonstrated that acute effects of anticholiner gics on the central nervous system may include a variety of psychiatric and cognitive disturbanc es, such as deficits in memory, attention, agita tion, hallucinations, and overt delirium. 75 Elder ly patients are more susceptible to these effects than younger individuals. 76 This is thought due to an age related decrease in cholinergic neurons and/or receptors, less efficient hepatic metabo lism and renal excretion of medications, and in creased blood brain barrier permeability. 77 De spite a lack of compelling evidence, these effects have generally been thought to be transient and reversible. Gray et al 78 followed 3434 cognitively normal individuals with cognitive evaluation bien nially for a mean follow up time of 7.3 years. They found higher cumulative anticholinergic use to be associated with increased risk for dementia.
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Vitamin deficiency Several vitamin deficiencies have been associated with an increased risk of de veloping cognitive impairment. Travica et al 79 con ducted a systematic review, which demonstrated higher mean vitamin C concentrations in cogni tively intact individuals compared with those who were cognitively impaired. 79 Moreover, there ap pears to be a potential association between plasma vitamin C concentrations and cognition; however, optimal vitamin C levels have not been established. Littlejohns et al 80 identified an association of vi tamin D deficiency with an increased risk of all cause dementia and AD. High vitamin E levels have been associated with a reduced risk of developing AD. 81 The proposed mechanism behind the po tentially protective effect of vitamin E is rooted in its antioxidant properties, given the growing body of evidence suggesting that free radical for mation may play a role in the pathophysiological mechanism underlying AD. However, supplemen tation should be reserved for use only when vita min E levels are low and then used with caution. A meta analysis by Miller et al 82 concluded that high dosage (≥400 IU/d) vitamin E supplements may increase all cause mortality.
Plasma levels of total homocysteine reflect the functional status of 3 B vitamins (folate, vita min B 12 , and vitamin B 6 ), and elevated homocyste ine level is a risk factor for the development of cog nitive decline, white matter changes, brain atrophy, neurofibrillary tangles, and dementia. Sleep apnea Obstructive sleep apnea (OSA) has been associated with neurocognitive and cardio vascular morbidities. 86 Neuropsychological defi cits of attention / vigilance, delayed long term vi sual and verbal memory, visuospatial / construc tional abilities, and executive functioning appear A subsequent study compared the Mediterranean, DASH, and MIND diets to determine their effect on the incidence of AD in 923 individuals. 64 They found that high adherence to all 3 diets was asso ciated with a reduced risk of AD, while moderate adherence to the MIND diet still resulted in a de creased, although to a lesser degree, risk of AD.
Medications Several classes of medications have been implicated in the development of cognitive dysfunction. However, with improved study mea sures, many of these assumptions have been dis proven. Such is the case of statin use, which was reported with memory loss and confusion that resolved after medication usage was stopped.
Since that time, studies have not substantiat ed this claim. A meta analysis encompassing 23 443 patients demonstrated no significant dif ferences in cognitive measures among those with statin therapy compared with placebo. 66 More re cently, Zissimopoulos et al 67 analyzed the associa tion between statin use and AD incidence for men and women of different races / ethnicities, using the 4 most commonly prescribed statins (simvas tatin, atorvastatin, pravastatin, and rosuvastatin). They found a decrease in AD incidence among all statin users, which was statistically significant in all groups except for black men. 67 Research in animal models has demonstrated that lansoprazole promoted higher Aβ40 levels in the brain 68 by increased amyloid production. Proton pump inhibitors (PPIs) are associated with vitamin B 12 deficiency, which, in turn, can lead to neurologic symptoms such as dementia. 69 In re cent years, several large prospective trials have been conducted to assess the risk of dementia with the use of PPIs. Data from 3076 patients in the German Study on Aging, Cognition and De mentia in Primary Care Patients found that pa tients receiving PPIs had an increased risk of all cause dementia (HR, 1.38; 95% CI, 1.04-1.83).
70
In the following year, Gomm et al 71 found similar results in their prospective study of 73 679 partic ipants derived from the largest German statutory health insurer. They found that those receiving regular PPI medication had increased risk of inci dent dementia compared with those not receiving PPI medication (HR, 1.44; 95% CI, 1.36-1.52).
71
Conversely, a prospective study of 13 864 middle aged and older women in the Nurses' Health Study II found no convincing association between PPI use and cognitive function. 72 In the same year, Taipale et al 73 looked at all 70 718 community dwelling individuals diagnosed with AD dur ing the years 2005 to 2011 in Finland and found no association with PPI use. More recently, Gray et al 74 performed cognitive screening on 3484 in dividuals every 2 years for a mean follow up of 7.5 years. They found that the use of PPIs, even at high cumulative exposure, was not associated with the risk of dementia or AD.
Anticholinergic medications are widely used for conditions ranging from overactive bladder to seasonal allergies. While many of these agents
up, inconsistent cognitive outcomes, and possible selective reporting. 91 For these reasons, they conclude that evidence does not support the use of any of these pharmacological treat ments for cognitive protection.
Over -the -counter medications In a similar review, Butler et al 92 reviewed 56 unique studies that as sessed the efficacy of over the counter supple ments as cognitive protection. Represented stud ies assessed ω 3 fatty acids, soy, ginkgo biloba, B vitamins, vitamin D plus calcium, vitamin C or β carotene, and multi ingredient supplements. Due to high attrition, short follow up, and the use of a highly variable set of cognitive outcome mea sures, the authors concluded that evidence is cur rently insufficient to recommend any over the counter supplement for cognitive protection.
Cognitive training Cognitive training has been studied as a means for preventing cognitive de cline. Butler et al 93 conducted a systematic re view representing 6 trials looking at populations with normal cognitive function. The authors con cluded that in older adults with normal cogni tion, training improves cognitive performance in the domain trained, while evidence regard ing prevention / delay of cognitive decline or de mentia was insufficient due to heterogenous in terventions and outcome measure, outcomes that mostly assessed test performance rather than global function or dementia diagnosis, and potential publication bias. The ACTIVE study 94 was a randomized, controlled single blind tri al with 3 intervention groups that participated in 10 training sessions for memory, reasoning, or speed of processing, with 4 session boost er training at 11 and 35 months after training. Ten year follow up data revealed that each in tervention group experienced less decline in self reported instrumental activities of daily living compared with controls. 95 Furthermore, reason ing and speed of processing training resulted in improved scores in the area of training.
Exercise While there is compelling evidence that exercise is healthy for the brain (see the Physical activity section), this has not been translated into effective prevention or treatment after the onset of dementia symptoms. 12 Valenzuela MJ. Brain reserve and the prevention of dementia. Curr Opinwho were randomized to the intervention (nutri tional intervention, a physical exercise training program, cognitive training, and vascular risk monitoring) or control groups. At 2 year follow up, the intervention group demonstrated 25% greater improvements on neuropsychological testing in specific cognitive domains of execu tive function, attention, and processing speed.
Conclusions
Despite the lack of level 1 evidence for most strategies, some activities associated with good brain health are reasonable to recommend. Ev idence does suggest that the multidomain approach will likely provide the greatest degree of protection; however, the details of this approach remain incom pletely studied. Based on the findings in this re view, we recommend several interventions that are generally associated with overall wellness (TABLE 1) .
The rise in prevalence of cognitive impairment in creases the urgency to find better means of pre vention. We expect that the results of ongoing and future studies will lead to improved strategies for the prevention of cognitive decline and dementia.
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